Company Overview

International Flavors & Fragrances Inc. (IFF) is a global specialty chemicals company that develops and manufactures ingredients used in food, beverage, health, biosciences, scent, and personal care products. The company operates at the intersection of food ingredients, flavors, fragrances, and biotechnology, supplying business-to-business customers across consumer packaged goods, pharmaceutical, and industrial markets. IFF’s core revenue drivers are the formulation and sale of value‑added ingredients that enhance taste, aroma, texture, nutrition, and functional performance in end products.

Founded in 1958 through the merger of Polak & Schwarz and Van Ameringen-Haebler, IFF initially focused on flavors and fragrances before expanding significantly through acquisitions and internal R&D. A major transformation occurred with the 2021 merger of IFF’s legacy business with DuPont’s Nutrition & Biosciences (N&B) division, which repositioned the company as a broader ingredients and biosciences platform. This evolution has given IFF scale, diversified revenue streams, and a strategic emphasis on science-driven solutions supported by proprietary fermentation, enzyme, and formulation technologies.

Business Operations

IFF organizes its operations into four primary business segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. Nourish generates the largest share of revenue and includes flavors, functional ingredients, plant-based solutions, and food systems used by global food and beverage manufacturers. Health & Biosciences focuses on enzymes, cultures, probiotics, and specialty ingredients serving dietary supplements, animal nutrition, and industrial applications. Scent develops fragrance compounds for fine fragrances, home care, and personal care products, while Pharma Solutions supplies excipients and delivery systems for pharmaceutical and biopharmaceutical customers.

The company operates an integrated global manufacturing and innovation network, leveraging fermentation facilities, botanical extraction, chemical synthesis, and formulation labs. IFF maintains long-term supply relationships with multinational consumer goods companies and also serves regional and emerging-market customers. Operations span both domestic and international markets, with revenue broadly diversified across end uses and geographies, reducing dependence on any single customer or region.

Strategic Position & Investments

IFF’s strategy emphasizes portfolio optimization, margin improvement, and innovation-led growth, particularly in higher-value, science-based ingredient solutions. Following the DuPont N&B transaction, the company has undertaken divestitures of non-core assets to reduce leverage and sharpen focus on its core segments. Notable actions include the sale of certain food ingredient and cultures businesses, with proceeds directed toward debt reduction and balance sheet strengthening.

Investment priorities center on biotechnology, enzyme engineering, fermentation-based solutions, and sustainable ingredients that address health, wellness, and environmental trends. IFF continues to invest heavily in R&D and application development to deepen customer integration and accelerate co-creation. The company also maintains a portfolio of subsidiaries aligned to its operating segments, with no publicly disclosed joint ventures that materially alter control or revenue recognition based on available public filings.

Geographic Footprint

IFF is headquartered in New York, United States, and operates a globally diversified footprint spanning North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. The company maintains manufacturing plants, innovation centers, and commercial offices across more than 40 countries, supporting both global and local customer needs.

Its largest markets by revenue include North America and Europe, with growing exposure to Asia-Pacific and emerging markets driven by rising consumer demand for packaged foods, personal care products, and health-related ingredients. International operations account for a substantial majority of total revenue, reflecting IFF’s role as a globally integrated supplier with significant cross-border operational and investment influence.

Leadership & Governance

IFF is led by an experienced executive team with backgrounds in global manufacturing, life sciences, and consumer-facing industries. The company emphasizes a governance framework focused on operational discipline, innovation, sustainability, and long-term shareholder value, with strategic oversight provided by an independent board of directors.

Key members of the leadership team include:

• Erik Fyrwald – Chief Executive Officer
• Michael C. Smith – Chief Financial Officer
• Erick Dubois – President, Nourish
• Leticia Gonçalves – President, Health & Biosciences
• Ana Paula Mendonça – President, Scent
• Chris Copley – Chief Human Resources Officer
• Christina Zamarro – Chief Accounting Officer

The leadership team’s stated strategic vision centers on leveraging science and creativity to deliver sustainable, differentiated ingredient solutions while improving financial performance and simplifying the operating model.